Abstract
This paper investigates the liquidity of pharmaceutical firms Listed in the Hanoi Stock Exchange (HNX) by using table data for the period 2015-2019. Four observedvariables were formulated including: (i) Cash Ratio (CR), (ii) Quick Ratio (QR), Current Ratio (CCR) and Interest Coverage Ratio (ICR). The findings conclude that have significantly different in the liquidity of pharmaceutical firms Listed in the HNX, in the long and shortrun. The implication of our results shows that the liquidity of pharmaceutical firms were interested by objects, including business administrators, creditor and other objects to have the necessary rationale for making a decision.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
